Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2025MedScienOpen Access

Gene Editing Using CRISPR/Cas9 System in the Treatment of HIV and Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

BCB. Chen

Discussion

Loading...

Member takes

Overview

Systematic review reveals CRISPR/Cas9 effectiveness in HIV and cancer therapies, highlighting urgent design challenges.

Key Points

  • CRISPR/Cas9 offers a promising method for targeting HIV and cancers, but challenges remain.
  • The gene editing system can enhance immune cell functions to promote cancer cell apoptosis.
  • Review of in vitro and animal studies highlights the importance of delivery efficiency and safety.
  • Research emphasizes the necessity of smarter delivery vectors for clinical translation of CRISPR technology.

Cite This Study

B. Chen (2025) studied this question.

synapsesocial.com/papers/68af7c8d7567bf4f94ff3e9fhttps://doi.org/10.61173/de7yak51
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Can CRISPR-Cas be used to cure HIV/AIDS?2025
  2. 2Precision Strikes on HIV: CRISPR/Cas9-Mediated Disruption of CCR5 and CXCR4 to Block Viral Entry and Establish Cellular Immunity2025
  3. 3The CRISPR-Cas9 Technology Used for the Treatment of Single-Gene Genetic Diseases2025
  4. 4<scp>CRISPR</scp> Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential2025 · 12 citations
  5. 5Challenges and Opportunities in the Application of CRISPR-Cas9: A Review on Genomic Editing and Therapeutic Potentials2025 · 27 citations